Last updated on :13 Nov, 2026
Read time :16 min
Have you ever been offered a different medicine brand because your regular one was unavailable? Two medicines may contain the same active ingredient, commonly called the salt, but that does not always mean you can switch between them without checking. The composition printed on a medicine strip helps you identify the active ingredients, their strengths and important formulation details.
Quick answer: To compare two medicine brands, check the active ingredient or salt, strength, dosage form and release type, such as SR or XL [1]. These details help identify whether two medicines may be comparable, but matching labels alone do not guarantee that they are interchangeable. Always ask your pharmacist or doctor to check a proposed substitute before switching.
Below, we explain how to read a medicine strip, what common abbreviations mean and when switching brands needs extra care.
In India, “salt” is the word commonly used for a medicine’s active ingredient, the substance that treats the condition. Its generic name stays the same whoever makes it. The brand name, printed larger on the front, is the company’s own name for the product.
Compare the full ingredient name on both packs, not just a familiar word in it. For example, metoprolol succinate and metoprolol tartrate share the name metoprolol, but they are different forms of the medicine and are not taken the same way.
The composition line gives the details that decide whether two packs match. Here is how to read a typical one: “Each film-coated tablet contains: Metformin Hydrochloride IP 500 mg”.
| Part of the label | What it tells you | In this example |
| Salt | The generic name of the medicine inside | Metformin hydrochloride |
| Strength | How much of the salt each unit holds | 500 mg |
| Form | The type of medicine | Film-coated tablet, a tablet with a thin outer coating |
| IP | Indian Pharmacopoeia, India’s official medicine standards [2]. Some packs show BP or USP. | IP |
| Brand name | The company’s own name, printed larger on the front | Differs between makers |
IP, BP and USP stand for the Indian, British and United States Pharmacopoeia. These are official books of quality standards, not brands or makers. The Indian Pharmacopoeia sets the tests for a medicine’s identity, purity and strength [2]. Packs marked IP and BP can contain the same salt. The letters tell you which standard the medicine meets, not who made it or whether two packs match. Read the composition line on both packs, because the brand names on the front will differ.
| Check | Compare | A mismatch looks like |
| Salt | Every salt on both packs | One salt on the old pack, two on the new |
| Strength | mg per tablet, per 5 ml for syrup [3], per ml for drops | 250 mg where you were prescribed 500 mg |
| Form | Tablet, capsule, syrup, drops | A syrup in place of a tablet |
| Release letters | MR, SR, XL or LA after the name [1] | A plain tablet in place of an SR tablet [1] |
If any line differs, do not take the new pack. Take both strips to your pharmacist or doctor the same day, so a daily medicine is not missed.
Strength needs extra care with syrups. Paracetamol syrups can differ in strength per 5 ml [3]. Paracetamol drops are usually much stronger than syrup and are measured per 1 ml, so never use a syrup dose for drops. Your child’s dose in ml depends on which syrup you have, their age and sometimes their weight [3]. Ask the pharmacist to work out the new dose in ml before you give it.
Brands of the same medicine often look different. One maker’s tablet may be white and round, another’s yellow and oval, and pack designs vary. A different look does not by itself mean the medicine is different, and a similar look does not mean it is the same. Only the composition line tells you what is inside, so compare that instead of the tablet or the pack.
A modified-release medicine may have MR, SR, XL or LA in its name. Such tablets let the medicine out slowly, or only under set conditions. A plain tablet of the same salt and strength is not a straight swap. The number of doses a day will likely need to change, so let your doctor or pharmacist make that switch.
Do not crush a modified-release tablet unless your pharmacist says you can. Crushing can release the whole dose at once, raising blood levels and the risk of harmful effects. It can also release the medicine in the wrong part of the gut, where it may not work [1].
Some tablets combine two or more salts. Match each one against your prescription. Two packs for different complaints can carry the same salt, so read the composition line on every medicine you take together. Taking the same salt twice can mean a double dose.
Our guide to common medication mistakes covers more errors like this.
Besides the salt, medicines contain excipients, ingredients that help with taste, texture and manufacture. Two makers, or two strengths from the same maker, may use different ones [4]. Most excipients have no effect on how the medicine works [4], so different excipients do not usually make one brand clinically different from another. They matter when you need to avoid a particular ingredient.
Some people avoid certain excipients for reasons of diet, culture or religion. Gelatine, for example, is made from animal collagen [4]. If you avoid animal products, are lactose intolerant or have an allergy, ask the pharmacist to check the new brand’s ingredients first [4].
Matching salt, strength, form and release letters show that two packs contain the same medicine at the same strength. Whether you can switch is still a decision for your pharmacist or doctor. For most medicines this is straightforward. For a few, small differences between makers can matter, so doctors may prefer patients to stay on one product. This applies to some epilepsy medicines and, for some people, thyroxine [5], [6].
Even when all four checks match, call your doctor before switching some epilepsy medicines [5]. With thyroxine, tell your doctor if you feel different after a switch [6].
UK safety guidance sorts epilepsy medicines by how much care a change of maker needs [5].
| Medicine | What UK safety guidance says |
| Carbamazepine, phenobarbital, phenytoin, primidone | Keep patients on one maker’s product [5] |
| Lamotrigine, valproate, topiramate and several others | Doctor and patient decide together, weighing how often seizures happen and how past treatment has gone [5] |
With the first four, products from different makers may differ enough to affect treatment. That can happen even when the tablets are the same type and tests show the medicine reaches the blood in the same way [5]. If the chemist offers a new brand of any of these medicines, call your doctor before you take it. Make that call the same day, so a daily dose is not missed.
UK safety guidance says generic thyroxine (levothyroxine) suits most people. A small number report symptoms after a change, often like those of a thyroid running too slow or too fast. Doctors may then test thyroid function and keep the person on one product if symptoms continue [6].
If you feel different after a new thyroxine brand, ask your doctor about a blood test. Do not change the dose yourself.
Report any new side effect after a brand change to your doctor. You can also call the Pharmacovigilance Programme of India (PvPI), the government’s scheme for medicine side effects. Its toll-free helpline is 1800-180-3024 [7].
Scan the QR code or barcode and compare what it shows with the printed pack. The code must hold [8]:
Since 1 August 2023, batches of 300 government-listed brands must carry the code, and other makers can choose whether to add one [8]. In June 2026, the government extended the requirement to more groups of medicines, with phased start dates [9]:
For these groups, the code will also include details of excipients where applicable [9]. Until these dates, many genuine packs outside the original 300 brands may not carry a code.
If the scanned details do not match the pack, do not take it, and show it to the pharmacist. Batch numbers and expiry dates are explained in how to check medicine expiry dates.
In India, medicine prices are regulated by the National Pharmaceutical Pricing Authority (NPPA) under the Drugs (Prices Control) Order, 2013. The table below summarises the main rules, although NPPA also has other price-fixing powers [10].
| Medicine group | Price rule |
| Medicines on the price-control list | NPPA fixes a ceiling price and revises it every year [10] |
| New drugs, as defined in the price-control order | NPPA fixes the retail price, and the maker cannot sell above it [10] |
| All other medicines | The maker generally cannot raise the maximum retail price (MRP) by more than 10% in 12 months [10] |
| Any medicine, in exceptional circumstances | NPPA can regulate the price in the public interest [10] |
| Generics at Jan Aushadhi Kendras | Priced generally 50% to 80% below similar brands [11] |
Medicines at Jan Aushadhi Kendras come only from makers that follow the World Health Organization’s good manufacturing practice, a set of quality rules for factories. Every batch is tested in an accredited laboratory and sent out only after it passes. Over 18,000 kendras are open, and the Jan Aushadhi Sugam app finds the nearest one and compares prices [11].
India’s code of ethics for doctors, amended in 2016, says they should prescribe by generic name, legibly and preferably in capital letters [12]. If your prescription carries only a brand name, ask your doctor to add the generic name and strength.
Which medicines need a prescription is explained in our guide to OTC vs prescription medicines.
If the chemist offers a different brand, these steps help you check it:
Match the salt, strength, form and release letters such as SR or XL, including every salt in a combination tablet. If all four match, the new pack holds the same medicine at the same strength, though its other ingredients can differ. If anything does not match, show both packs to your pharmacist the same day. For some epilepsy medicines and thyroxine, check with your doctor before switching, even if everything matches.
For a few medicines, yes. Some epilepsy medicines from different makers may differ enough to affect treatment, so UK safety guidance asks doctors to keep patients on one maker. A small number of people report symptoms after changing thyroxine products. If you feel different after a switch, tell your doctor.
Within these rules, each maker sets its own price, so brands differ. The NPPA fixes ceiling prices for medicines on the price-control list and retail prices for certain new drugs, and can regulate other prices in exceptional circumstances. For most other medicines, a maker generally cannot raise the MRP by more than 10% in 12 months. Jan Aushadhi Kendras sell generics at prices generally 50% to 80% below similar brands.
Scan the QR code or barcode if the pack has one. Check the details match the printed pack, though a fake pack can copy a real code. Since August 2023, 300 government-listed brands must carry a code. The rule extends to vaccines, anti-cancer medicines, and narcotic and psychotropic medicines from July 2027, and to antimicrobials from July 2028. Until then, many genuine packs have no code. If the details do not match, show the pack to your pharmacist.
Check that the salt, strength, form and release letters match your prescription. Take it as directed on the packet or the leaflet, and only take antibiotics prescribed for you. If the new pack differs, show both packs to your pharmacist the same day.
Write the brand name next to the generic name on your medicine list, and update it each time the brand changes. Keep the old strip until the salt, strength, form and release letters are checked. Anyone who helps with your medicines, at home or in hospital, can then see at a glance what you take and from which maker.
DISCLAIMER: This content is for general information and education only. It is not medical advice, diagnosis or a substitute for consulting a professional. Advice can vary by brand and formulation. Always follow the instructions that came with your medicine and ask your doctor, pharmacist or qualified healthcare professional about your situation.
[1] NHS Specialist Pharmacy Service. (2025, February 6). Checking if tablets can be crushed or capsules opened. https://www.sps.nhs.uk/articles/checking-if-tablets-can-be-crushed-or-capsules-opened/
[2] Indian Pharmacopoeia Commission. (2023). About IP. Retrieved November 12, 2026, from https://ipc.gov.in/mandates/indian-pharmacopoeia/about-ip.html
[3] NHS. (2025). Paracetamol for children. https://www.nhs.uk/medicines/paracetamol-for-children/
[4] NHS Specialist Pharmacy Service. (2025, September 2). Understanding excipients in medicines. https://www.sps.nhs.uk/articles/understanding-excipients-in-medicines/
[5] Medicines and Healthcare products Regulatory Agency. (2017, November 24). Antiepileptic drugs: Updated advice on switching between different manufacturers’ products. GOV.UK. https://www.gov.uk/drug-safety-update/antiepileptic-drugs-updated-advice-on-switching-between-different-manufacturers-products
[6] Medicines and Healthcare products Regulatory Agency. (2021, May 19). Levothyroxine: New prescribing advice for patients who experience symptoms on switching between different levothyroxine products. GOV.UK. https://www.gov.uk/drug-safety-update/levothyroxine-new-prescribing-advice-for-patients-who-experience-symptoms-on-switching-between-different-levothyroxine-products
[7] Indian Pharmacopoeia Commission. (2025, September 4). IPC expands helpline number 1800-180-3024: Multilingual IVR system. https://ipc.gov.in/news-highlights/1399-ipc-expands-helpline-number-1800-180-3024-multilingual-ivr-system.html
[8] Central Drugs Standard Control Organisation. (2023, July 21). FAQs on implementation of GSR 823(E) dated 17th November, 2022 with respect to bar code or QR code on top 300 brands. Ministry of Health and Family Welfare, Government of India. https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadPublic_NoticesFiles/Final%20FAQs%20on%20QR%20code%2021.07.2023.pdf
[9] Press Information Bureau, Ministry of Health and Family Welfare. (2026, June 25). Union Health Ministry expands QR code-based drug traceability framework to vaccines, antimicrobials and anti-cancer medicines [Press release]. https://www.pib.gov.in/newsite/archiveContent.aspx?lang=2®=48&relid=290478
[10] Press Information Bureau, Ministry of Chemicals and Fertilizers. (2025, December 9). Measures to prevent overpricing and unethical practices [Press release]. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2200935
[11] Press Information Bureau. (2026, March 7). Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP): Advancing affordable and equitable healthcare [Backgrounder]. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2236292
[12] Medical Council of India. (2016). Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 (amended up to 8 October 2016). National Medical Commission. https://nmc.org.in/storage/cms/Ethics-Regulations-2002.pdf
Disclaimer
Our healthcare experts have carefully reviewed and compiled the information presented here to ensure accuracy and trustworthiness. It is important to note that this information serves as a general overview of the topic and is for informational purposes only. It is not intended to diagnose, prevent, or cure any health problem. This page does not establish a doctor-patient relationship, nor does it replace the advice or consultation of a registered medical practitioner. We recommend seeking guidance from your registered medical practitioner for any questions or concerns regarding your medical condition.
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorAdvertise with UsSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.28.26
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

